Executive Summary
Generated July 30, 2026
Semiconductor Manufacturing
Kinsus Interconnect Technology
Strategic importance is our editorial rating of how central this entity is to the technology landscape we track; confidence reflects how well-sourced and current the underlying evidence is.
1
Chokepoint Score
1 other entity structurally depend on this one
Cooling
Activity
0 recorded changes in the last 90 days
Headquarters
Taoyuan, Taiwan
Website
Listing
3189 · Taiwan Stock Exchange
Market Cap
TWD 303.50B
Revenue (TTM)
TWD 41.84B
Price
TWD576 (-26.62%)
Market data as of Jul 29, 2026, 11:25 AM · Source: Yahoo Finance (delayed). Not investment advice.
Overview
A Pegatron-affiliated IC substrate maker that supplies customers including NVIDIA and AMD, approving a US$744 million ABF (Ajinomoto Build-up Film) substrate capacity expansion in early 2026 on a three-year demand outlook; separately piloting a Penang, Malaysia facility as a manufacturing-diversification move, with initial trial production aimed at automotive, consumer-electronics and memory-chip customers rather than AI accelerators specifically.
Strategic Connections
- Advanced Semiconductor Packaging: Kinsus manufactures high-end ABF IC substrates used in advanced chip packaging, expanding capacity on a three-year tight-supply outlook for the segment.
Strategic Risks
- Malaysia operation remains a smaller trial-scale facility oriented toward automotive/consumer/memory customers, not yet a confirmed AI-accelerator substrate source
- High-end ABF substrate capacity additions carry long lead times and qualification cycles relative to how fast AI demand can shift
Future Outlook
- Malaysia capacity could expand toward AI-substrate production if the initial automotive/consumer trial succeeds, per company statements at the time
- US$744M ABF expansion aimed at relieving a persistent high-end substrate supply crunch through 2026 and beyond
Sources
2 sources, 69% average source confidence — full citations in the Full Analyst Report.
Generated by InsightNodes — Technology Intelligence Platform. This report reflects sourced, evidence-backed information as of the dates cited above and is not investment advice.
Viewing the Executive Summary — switch to the Full Analyst Report.